Bioscience Animal Health PCL (BKK:BIS)

Market Cap	624.86M -27.9%
Revenue (ttm)	2.31B -2.8%
Net Income	38.47M -40.8%
EPS	0.12 -40.6%
Shares Out	314.00M
PE Ratio	16.18
Forward PE	n/a
Dividend	0.17 (8.50%)
Ex-Dividend Date	Apr 29, 2026

Volume	140,503
Average Volume	133,966
Open	2.000
Previous Close	2.000
Day's Range	1.930 - 2.000
52-Week Range	1.700 - 3.120
Beta	0.69
RSI	44.40
Earnings Date	Feb 27, 2026

About BKK:BIS

Bioscience Animal Health Public Company Limited manufactures, imports, and distributes pharmaceutical supplies, devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. The company also exports its products. Bioscience Animal Health Public Company Limited was incorporated in 2004 and is based in Nonthaburi, Thailand.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2004
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BIS

Financial Performance

In 2025, BKK:BIS's revenue was 2.31 billion, a decrease of -2.83% compared to the previous year's 2.37 billion. Earnings were 38.47 million, a decrease of -40.85%.